LumoDX

Urbana, United States Founded: 2016 • Age: 10 yrs
Develops optical technology for effective oral cancer screening in healthcare settings.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About LumoDX

LumoDX is a company based in Urbana (United States) founded in 2016 by Aashay Patel. It operates as a B2B. LumoDX operates in a competitive market with competitors including Viome Life Sciences, Vigilant Biosciences, Erly Sign, Proteocyte and PeriRx, among others.

  • Headquarter Urbana, United States
  • Founders Aashay Patel
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of LumoDX

Premium access

Detailed funding history for LumoDX

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by LumoDX

Investments
Premium access

Investment portfolio details for LumoDX

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - LumoDX

Premium access

Detailed financials for LumoDX

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lumodx Comparisons

LumoDX Primary company
Description
Develops optical technology for effective oral cancer screen...
Location
Urbana, United States
Founded Year
2016
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for LumoDX

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of LumoDX

LumoDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Vigilant Biosciences, Erly Sign, Proteocyte and PeriRx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
Locked Locked Locked
Solutions for early oral cancer detection are developed and provided.
Locked Locked Locked
A platform providing test kits for detecting oral cancer
Locked Locked Locked
Diagnostic tests for predicting cancer development risks are provided.
Locked Locked Locked
Saliva-based tests for oral cancer risk stratification are developed.
Locked Locked Locked
Saliva-based tests for periodontal disease and infections are developed.
Premium access

Detailed competitors of LumoDX

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lumodx

Premium access

Complete news archive for LumoDX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LumoDX

LumoDX was founded in 2016.

LumoDX is headquartered in Urbana, United States. It is registered at Urbana, Illinois, United States.

Aashay Patel is the current CEO of LumoDX. They have also founded this company.

LumoDX, founded in 2016 in Urbana, United States, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and cancer screening. Develops optical technology for effective oral cancer screening in healthcare settings. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

LumoDX's top competitors include Viome Life Sciences, Erly Sign and Vigilant Biosciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available